Wake Forest Translational Alcohol Research Center (WF-TARC)
Project Number5P50AA026117-07
Former Number5P50AA026117-05
Contact PI/Project LeaderWEINER, JEFFREY L
Awardee OrganizationWAKE FOREST UNIVERSITY HEALTH SCIENCES
Description
Abstract Text
WAKE FOREST TRANSLATIONAL ALCOHOL RESEARCH CENTER (WF-TARC)
OVERALL SUMMARY
The central goal of the Wake Forest Translational Alcohol Research Center (WF-TARC) is to employ
integrated, translational animal and human subjects research to study behavioral correlates and
neurobiological substrates associated with vulnerability and resilience to alcohol use disorder (AUD). This
Center builds on a highly productive translational alcohol research program at WFSM that led to the awarding
of this P50 grant in 2017.
The WF-TARC is comprised of four research projects and two cores. An administrative core provides the
leadership and infrastructure needed to ensure integration across all research projects. This core also provides
biostatistical support and promotes interactions and communication between this Center and the many other
addiction-related research and educational programs at Wake Forest School of Medicine (WFSM). A pilot
project core serves to advance the goals and objectives of the WF-TARC. This core funds projects each year
to attract new investigators to bring their talent and expertise to the study of AUD vulnerability.
The unifying research focus of the WF-TARC is to leverage the unique strengths and advantages of animal
and human subjects research to study behavioral correlates of AUD vulnerability and identify neurobiological
adaptations that contribute to this heightened risk of developing this disorder. These studies employ cutting-
edge, multidisciplinary experimental approaches spanning molecular, cellular, circuit, and whole-brain
analyses. Importantly, studies in each project are also seeking to improve AUD treatment outcomes. The well-
integrated conceptual framework and research design facilitates backward and forward interactions across all
projects, facilitating the rapid translation of therapeutic discoveries from animals to humans.
The WF-TARC leverages a well-established, highly collaborative translational alcohol research program at
WFSM and benefits from a strong and growing institutional focus on alcohol and substance use disorders.
This Center will continue to enhance the outstanding educational environment at our institution, providing
unique training opportunities for the students and postdoctoral who will become the next generation of
translational alcohol researchers. Finally, the innovative research supported by the WF-TARC may lead to
improved evidence-based therapies for individuals who are at greatest risk of developing AUD, individuals who
are particularly ill-served by current AUD treatment options.
Public Health Relevance Statement
PROJECT NARRATIVE
The overarching research focus of the Wake Forest Translational Alcohol Research Center (WF-TARC) is to
study behavioral correlates associated with heightened vulnerability to alcohol use disorder and identify
neurobiological adaptations responsible for these behaviors. The highly integrated experimental design of this
renewal continues to leverage the unique benefits of rodent, nonhuman, and human subjects research and
facilitates backward and forward translation between projects. Collectively, these studies may lead to novel
therapeutic interventions for individuals at greatest risk of developing alcohol alcohol use disorder.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AccelerationAdolescentAlcohol consumptionAlcoholsAnimal ModelAnimalsAwardBehaviorBehavioralBiometryBrainCollaborationsCommunicationCommunity Health EducationDevelopmentDiagnosisDiseaseEducationEducation and OutreachEnsureExperimental DesignsFacultyFundingGoalsGrantGrowthHealthcare SystemsHumanHuman Subject ResearchIndividualInfrastructureInstitutionKnowledgeLeadershipLearningMeasuresMethodsMolecularNeurobiologyPilot ProjectsPlayPopulationPopulations at RiskPostdoctoral FellowPre-Clinical ModelProductivityResearchResearch DesignResearch MethodologyResearch PersonnelResearch Project GrantsResearch SupportResourcesRiskRodentRoleScienceSleep disturbancesStudentsSubstance Use DisorderSystemTalentsTranslational ResearchTranslationsTreatment outcomeWorkaddictionalcohol abuse therapyalcohol researchalcohol use disorderbehavioral studydrinking behavioreducational atmosphereeffective therapyevidence basehuman modelimprovedinnovationmedical schoolsmorphogensmultidisciplinaryneuralneural correlateneurodevelopmentnext generationnonhuman primatenovelnovel strategiesnovel therapeutic interventionpredictive modelingprogramsrecruitresiliencesuccesstraining opportunitytranslational therapeutics
National Institute on Alcohol Abuse and Alcoholism
CFDA Code
273
DUNS Number
937727907
UEI
SN7KD2UK7GC5
Project Start Date
10-December-2017
Project End Date
30-November-2027
Budget Start Date
01-December-2023
Budget End Date
30-November-2024
Project Funding Information for 2024
Total Funding
$1,552,610
Direct Costs
$1,627,264
Indirect Costs
$896,699
Year
Funding IC
FY Total Cost by IC
2024
National Institute on Alcohol Abuse and Alcoholism
$1,552,610
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P50AA026117-07
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P50AA026117-07
Patents
No Patents information available for 5P50AA026117-07
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P50AA026117-07
Clinical Studies
No Clinical Studies information available for 5P50AA026117-07
News and More
Related News Releases
No news release information available for 5P50AA026117-07
History
No Historical information available for 5P50AA026117-07
Similar Projects
No Similar Projects information available for 5P50AA026117-07